Clinical Trial Update: Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity

View source ↗

Summary

A clinical trial evaluating weight trajectories and predictive factors after semaglutide in patients with grade 3, complicated obesity; recruitment has not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Nantes University Hospital | Conditions: Obesity & Overweight | Status: NOT_YET_RECRUITING